- Patient characteristics and CEA, CA 125, and CA 15-3 tumor marker levels in the study population..
| Characteristics | n (%) |
|---|---|
| Gender | |
| Male | 92 (1.3) |
| Female | 6,924 (98.7) |
| Age (years) | |
| 15-30 | 1,198 (17.1) |
| 31-40 | 1,759 (25.1) |
| 41-50 | 1,483 (21.1) |
| 51-60 | 1,138 (16.2) |
| 61-70 | 848 (12.1) |
| 71-80 | 433 (6.2) |
| 81-90 | 129 (1.8) |
| 91-100 | 28 (0.4) |
| Demographic regions | |
| Northern Region | 296 (4.2) |
| Central Region | 2,072 (29.5) |
| Eastern Region | 524 (7.5) |
| Western Region | 3,007 (42.9) |
| Southern Region | 1,117 (15.9) |
| Classification | |
| Referred by hospital | 465 (6.6) |
| Self-referred | 6,551 (93.4) |
| CEA levels | |
| Abnormal | 150 (2.1) |
| Normal | 6,866 (97.9) |
| CA 125 levels | |
| Abnormal | 375 (5.3) |
| Normal | 6,641 (94.7) |
| CA 15-3 levels | |
| Abnormal | 114 (1.6) |
| Normal | 6,902 (98.4) |
Values are presented as numbers and percentages (%).
CEA: carcinoembryonic antigen, CA 125: cancer antigen 125, CA 15-3: cancer antigen 15-3